Despite these strengths, there remain some limitations of our work, including limited participant diversity, a lack of information to definitively determine whether surgeries to remove breasts and/or ovaries were based on CHEK2 status versus part of the medical treatment for breast cancer, and a lack of data to determine if compliance with annual breast MRIs was met. The gene discussed is CHEK2; the disease is breast carcinoma.